Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000039122 | SCV000062804 | likely benign | not specified | 2016-06-28 | criteria provided, single submitter | clinical testing | p.Thr731Thr in exon 21 of CDH23: This variant is not expected to have clinical s ignificance because it does not alter an amino acid residue, is not located with in the splice consensus sequence, and it has been identified in 0.4% (51/11414) of Latino chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.bro adinstitute.org; dbSNP rs397517315). |
Labcorp Genetics |
RCV000909993 | SCV001054834 | benign | not provided | 2025-01-13 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000909993 | SCV001804949 | likely benign | not provided | 2021-10-12 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001831657 | SCV002085539 | likely benign | Usher syndrome type 1 | 2019-12-12 | no assertion criteria provided | clinical testing | |
Prevention |
RCV004534823 | SCV004742278 | likely benign | CDH23-related disorder | 2019-11-01 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |